{"id":855,"date":"2017-09-25T16:18:39","date_gmt":"2017-09-25T10:48:39","guid":{"rendered":"https:\/\/babrone.avfu.ac.in\/blog\/?p=855"},"modified":"2018-11-12T10:16:47","modified_gmt":"2018-11-12T04:46:47","slug":"research-highlights-fourth-issue","status":"publish","type":"post","link":"https:\/\/babrone.avfu.ac.in\/blog\/?p=855","title":{"rendered":"Research Highlights (Fourth Issue)"},"content":{"rendered":"<p style=\"text-align: center;\"><span style=\"color: #2d08ca;\"><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: large;\"><b>Diagnose cancer just in seconds<\/b><\/span><\/span><\/span><\/p>\n<p style=\"text-align: justify;\" align=\"JUSTIFY\"><span style=\"color: #000000;\"><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">The contemporary methods available to diagnose cancer are either time-consuming or inaccurate in differentiating healthy and cancerous tissue. To overcome these problems, researchers from University of Texas, Austin in the US have developed a pen-like mass spectrometry device, named as <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><b>\u2018MasSpec Pen\u2019. <\/b><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">The device is handheld; it not only identifies cancerous tissue within 10 seconds but also accurately differentiates cancerous and normal tissues during surgery, and lessens the chance of reoccurrence of cancer. The metabolites, lipids and protein profiles of normal and cancerous tissues are significantly different and they act as molecular fingerprints or potential biomarkers. The MasSpec pen delivers a controlled water droplet to an uncharacterized tissue sample, efficiently extracts the metabolites in the water droplet and analyses the molecular profile of that tissue using software and database, and finally interprets it as \u2018normal\u2019 or \u2018cancerous\u2019 on the basis of the molecular fingerprint. The device is highly sensitive (96.4%) and specific (96.2%) with overall accuracy of 96.3%. The team also successfully diagnosed cancer during surgery in mouse model bearing tumour without any healthy tissue injury and strain to the mice. Finally, they remarked that the MasSpec pen can be used for diagnosis of cancer both <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>ex vivo<\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"> and <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>in vivo<\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">.<\/span><\/span><\/span><\/p>\n<p align=\"JUSTIFY\"><em><span style=\"color: #000000;\"><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">(<\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">Science Translational Medicine, <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><b>9<\/b><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><b>:<\/b><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"> eaan3968, (2017). DOI: 10.1126\/scitranslmed.aan3968)<\/span><\/span><\/span><\/em><\/p>\n<hr>\n<p align=\"CENTER\"><span style=\"color: #2d08ca;\"><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: large;\"><b>Food from air and electricity<\/b><\/span><\/span><\/span><\/p>\n<p style=\"text-align: justify;\" align=\"JUSTIFY\"><span style=\"color: #000000;\"><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">Food security is one of the major concerns of modern world due to continuous hike in population. Statistically, it has been established that 795 million people of the globe are suffering from chronic malnutrition. To vanquish this in the near future, Finnish researchers have successfully created a special food using CO<\/span><\/span><sub><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">2, <\/span><\/span><\/sub><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">electricity and few microbes. The designed food is in powder form consisting of more than 50% protein, 25% carbohydrates and rest 25% of lipids and nucleic acid which is designated as a <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><b>single-cell protein<\/b><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">. One gram of protein was produced in the laboratory in two weeks using a coffee-cup size equipment. This method of creating food is 10 fold more energy-efficient than the natural process of photosynthesis used for production of other protein-rich plant products such as soy. The ground-breaking method of producing single-cell protein could revolutionize the food and feed industries, and could be used as human food and animal feeds in famine-affected as well in desert areas.<\/span><\/span><\/span><\/p>\n<p align=\"JUSTIFY\"><em><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">(<a href=\"https:\/\/www.sciencedaily.com\/releases\/2017\/07\/170719090025.htm\">https:\/\/www.sciencedaily.com\/releases\/2017\/07\/170719090025.htm<\/a>)<\/span><\/span><\/em><\/p>\n<hr>\n<p align=\"CENTER\"><span style=\"color: #2d08ca;\"><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: large;\"><b>Retain garden-freshness of apples without chemical preservative<\/b><\/span><\/span><\/span><\/p>\n<p style=\"text-align: justify;\" align=\"JUSTIFY\"><span style=\"color: #000000;\"><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">Apple is a highly perishable fruit and is easily spoiled during packaging, transportation and storage. A fungal pathogen <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>Penicillium expansum <\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">causes blue mold in post-harvest apples which accounts for about 50% losses of the fruit. Although fungicides are available, due to increased resistance towards it and due to the associated public health concern, the modern science is in search of safer alternatives such as bio-control agents. In this direction, a scientific group from Canada has proved in their experiment that the gram-negative bacterium <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>Pseudomonas fluorescens <\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">could control blue mold in stored apples. The degree of controlling <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>Penicillium expansum<\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"> in cold stored apples was similar what could be provided by commercial fungicides and other agents. The team proposed that <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>P. fluorescens <\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">competes for nutrients and space with <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>P. expansum<\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">,<\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"> and produces metabolites which inhibit its growth in the stored apples. Thus, <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>P. fluorescens <\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">could be a potential biological alternative to control blue mold not only in post-harvest apples but also other perishable fruits. <\/span><\/span><\/span><\/p>\n<p><em><span style=\"color: #000000;\"><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">(<\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">Postharvest Biology and Technology, 133.<\/span><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><span style=\"color: #000000;\">&nbsp;(2017).<\/span>&nbsp;<a href=\"http:\/\/dx.doi.org\/10.1016\/j.postharvbio.2017.07.003\">DOI: 10.1016\/j.postharvbio.2017.07.003<\/a><\/span><\/span><span style=\"color: #000000;\"><span style=\"font-family: Arial, serif;\">)<\/span><\/span><\/em><\/p>\n<hr>\n<p align=\"CENTER\"><span style=\"color: #2d08ca;\"><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: large;\"><b>Expectation for potent AIDS vaccine from cows\u2019 antibodies<\/b><\/span><\/span><\/span><\/p>\n<p style=\"text-align: justify;\" align=\"JUSTIFY\"><span style=\"color: #000000;\"><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">Acquired immune deficiency syndrome (AIDS) is producing tremendous social and economic impact across the globe. Currently there is no cure and a promising vaccine against this disease. Scientists from different institutes of USA have documented a potent HIV-blocking antibody in cow which could bring new rays of hope to develop an effective AIDS vaccine in future. Due to continuous mutation, nature of the HIV virus and the antigenic diversity of its envelop protein, it has always been difficult to produce an effective vaccine against it and also it takes multiple years in infected humans to develop broadly neutralizing antibodies (bnAbs). But the team succeeded in producing broadly neutralizing antibodies in cows within few weeks using an immunogen <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><b>\u2018BG505 SOSIP\u2019.<\/b><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"> Although cows are resistant to HIV virus, its ability to produce bnAbs against such a complex and diverse virus have paved the path to develop a novel promising vaccine against AIDS for mankind. <\/span><\/span><\/span><\/p>\n<p align=\"JUSTIFY\"><em><span style=\"color: #000000;\"><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">(<\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">Nature, <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><b>548<\/b><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">: 108\u2013111, (2017). DOI:10.1038\/nature23301)<\/span><\/span><\/span><\/em><\/p>\n<hr>\n<p align=\"CENTER\"><span style=\"color: #2d08ca;\"><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: large;\"><b>Introductory antibody against canine cancer<\/b><\/span><\/span><\/span><\/p>\n<p style=\"text-align: justify;\" align=\"JUSTIFY\"><span style=\"color: #000000;\"><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">The rate of occurrence of cancer is increasing day by day in pet dogs and now it is one of the leading causes of death in dogs. Oral malignant melanoma (OMM) is one of the commonly encountered invasive cancers found in canines, which accounts for 30-40 per cent of all oral cancers. Till date, immunotherapy has gained momentum for treatment of cancer in human; however, no such immunotherapy is reported in case of canine cancer. Recently, a bench of Japanese scientists have developed a rat-dog chimeric antibody against immune checkpoint molecule <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><b>\u2018programmed cell death ligand 1(PD-L1)\u2019. <\/b><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">The antibody so developed blocks the PD-1\/PD-L1 axis and thereby induces potent anti-tumour immune responses which not only suppresses malignant oral cancer but also elevates the survivability rate of dogs suffering from OMM. The team concluded that the antibody could be a promising immunotherapeutic agent for treatment of other cancerous cells expressing PD-L1 molecules for which further clinical investigation is a prerequisite. <\/span><\/span><\/span><\/p>\n<p align=\"JUSTIFY\"><span style=\"color: #000000;\"><em><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">(<\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">Scientific Reports<\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">, <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><b>7:<\/b><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"> 8951, (2017). DOI:10.1038\/s41598-017-09444-2)<\/span><\/span><\/em><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Diagnose cancer just in seconds The contemporary methods available to diagnose cancer are either time-consuming or inaccurate in differentiating healthy and cancerous tissue. To overcome these problems, researchers from University of Texas, Austin in the US have developed a pen-like mass spectrometry device, named as \u2018MasSpec Pen\u2019. The device is handheld; it not only identifies&#8230;<\/p>\n","protected":false},"author":1,"featured_media":859,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"ngg_post_thumbnail":0,"footnotes":""},"categories":[21,154],"tags":[43],"class_list":["post-855","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-research-highlights","category-research-highlightsfourth-issue","tag-research-highlights"],"_links":{"self":[{"href":"https:\/\/babrone.avfu.ac.in\/blog\/index.php?rest_route=\/wp\/v2\/posts\/855","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/babrone.avfu.ac.in\/blog\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/babrone.avfu.ac.in\/blog\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/babrone.avfu.ac.in\/blog\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/babrone.avfu.ac.in\/blog\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=855"}],"version-history":[{"count":2,"href":"https:\/\/babrone.avfu.ac.in\/blog\/index.php?rest_route=\/wp\/v2\/posts\/855\/revisions"}],"predecessor-version":[{"id":861,"href":"https:\/\/babrone.avfu.ac.in\/blog\/index.php?rest_route=\/wp\/v2\/posts\/855\/revisions\/861"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/babrone.avfu.ac.in\/blog\/index.php?rest_route=\/wp\/v2\/media\/859"}],"wp:attachment":[{"href":"https:\/\/babrone.avfu.ac.in\/blog\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=855"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/babrone.avfu.ac.in\/blog\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=855"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/babrone.avfu.ac.in\/blog\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=855"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}